C9orf72 and amyotrophic lateral sclerosis: Research has shown that targeting the Kelch-1ike ECH- associated protein l (Keap1)/Nrf2 signaling pathway to combat mitochondrial oxidative stress represents a potential therapeutic strategy for C9orf72-related ALS (Au et al., 2024).